Medical Device Network on MSN21h
Bio-Rad set to acquire Stilla Technologies
Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...
Results from the company’s Talapro-2 trial saw a 38% reduction in the risk of death among HRR-mutated patients.
Applied DNA Sciences exits DNA Tagging business segment. Workforce reduction and GMP site completion announced. Financial results for Q1 fiscal 2025 revealed ...
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
OSANG Healthcare partners with KAIST, NANO to develop PCR tests for STIs Innovative partnership aims to enhance diagnostic ...
Quantitative polymerase chain reactions (PCRs) were performed to confirm differentially expressed RBPs in RA fibroblast-like synoviocytes (FLSs) and OA-FLSs, as well as in mice with collagen-induced ...
Korea lifts Mycoplasma pneumonia outbreak alert after eight months Outbreak alert for respiratory infection officially ...
GCCL is committed to customer success, emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...
Anillin (ANLN), a mitotic protein that regulates contractile ring assembly, has been reported as an oncoprotein. However, the function of ANLN in cancer cells, especially in the nucleus, has not been ...
Fapon has introduced its technology transfer and local manufacturing services to best underscore its commitment to enhancing ...